Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Early Diagnosis and Survival in Female Pelvic Cancer (e.g. Ovarian Cancer) With OC Detect, (Pilot Study)

NCT06613230 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT06613230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06613230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Early Diagnosis and Survival in Female Pelvic Cancer (e.g. Ovarian Cancer) With OC Detect, (Pilot Study)
Lead sponsor
Region Skane
Phase
Observational
Overall status
Completed
Start date
February 1, 2024
Completion date
December 31, 2024
Enrollment
490 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, endometrial cancer, lymphoma, malignant melanoma, ovarian cancer, sarcoma